CBN vs. CBD: one comes from aging THC, the other from the living plant
CBN is what THC turns into as it ages; CBD comes from an acid the living plant makes. What NIDA, the FDA and the published trials say, what is not established, and where both stand under federal law from Dec. 11, 2026.

See today's flower Shipping is free on every order.
The short answer. CBN forms as THC oxidizes with age, heat and light; CBD comes from an acid the living plant makes. NIDA says CBD is not intoxicating like THC and lists CBN among cannabinoids with limited research. Only CBD has an FDA-approved drug. As of Oct. 14, 2026, both stay hemp after Dec. 11, 2026 only within new limits.
Health facts here come only from the FDA, the National Institute on Drug Abuse (NIDA) and research indexed in NIH’s PubMed. The law comes from the statute text on GovInfo. For CBD’s other comparisons, see CBG vs. CBD and THC vs. CBD.
What is the difference between CBN and CBD?
| CBN (cannabinol) | CBD (cannabidiol) | |
|---|---|---|
| Formula | C21H26O2, 310.4 g/mol (PubChem) | C21H30O2, 314.5 g/mol (PubChem) |
| Where it comes from | Mostly THC that oxidizes after harvest | CBDA, an acid the living plant makes, once heat removes its carboxyl group |
| Intoxicating | Evidence mixed; NIDA lists it among “intoxicating cannabinoids and related compounds” with limited research | No: “not intoxicating like THC” (NIDA) |
| FDA-approved drugs | None | Epidiolex, for certain seizure disorders (FDA) |
| FDA safety warnings | None specific to CBN that we found | Liver injury, drug interactions, sedation (FDA) |
| Human research | Small studies, most from the 1970s and 1980s (2021 review), and a few small trials since | FDA-reviewed trials behind Epidiolex |
| Named in Schedule I | No | No |
| From Dec. 11, 2026 | Hemp only within the new limits; open question on the HHS list | Hemp only within the new limits |
CBN has four fewer hydrogen atoms than CBD and THC, which share the formula C21H30O2 (PubChem). Losing hydrogen is what oxidation does to THC. The letters are close; the chemistry and the evidence are not, and research on one says nothing about the other.
How does CBN form?
Mostly from THC, after the plant is cut. The authors of a 2026 trial describe cannabinol as “an oxidative by-product of Δ9-tetrahydrocannabinol” (Lavender and others, Journal of Sleep Research, 2026). Two studies show the process:
- Time and light. A forensic team stored six high-potency cannabis samples for four years. At room temperature, in light or in darkness, THC fell and CBN rose, and “almost 100% of THC was degraded after four years.” Temperature changed the speed of the conversion; light changed both its speed and the ratio of CBN formed to THC lost (Zamengo and others, Forensic Science International, 2019).
- Heat. In cannabis resin held at 50 °C to 80 °C, THC broke down and CBN formed faster as the temperature rose (Jaidee and others, Cannabis and Cannabinoid Research, 2022).
CBD takes a different route. The plant builds cannabigerolic acid (CBGA), and an enzyme, CBDA synthase, closes it into cannabidiolic acid (Taura and others, 1996). Heat then removes the acid’s carboxyl group, which the USDA defines as decarboxylation (7 CFR 990.1). So CBN tells you how much THC has aged; CBD tells you what the plant was bred to make. On a lab report, a rising CBN line next to a falling THC line reads as a sign of age or warm storage; our COA guide shows where each line sits.
Does CBN get you high?
For CBD, NIDA is direct: “CBD is not intoxicating like THC.”
For CBN, the federal wording is cautious. NIDA writes: “There is limited research on the health effects delta-8-THC and other intoxicating cannabinoids and related compounds, including delta-10-THC, THC-O-acetate, THCV, THCP, HHC, HHC-O-acetate, HHCP, and CBN.” That puts CBN in the group, without a finding about how strong it is.
The human trials are small and old. In a 1975 study, five men took 50 mg of CBN by mouth; on a drug-reaction scale they reported feeling “drugged, drunk, dizzy, and drowsy” after THC “but not under the CBN condition” (Karniol and others, Pharmacology, 1975). A 2021 review of the human literature concluded that “evidence demonstrating that CBN itself elicits cannabis-like effects in humans is mixed, with the majority of available evidence demonstrating a lack of such an effect” (Corroon, Cannabis and Cannabinoid Research, 2021). A small, mixed record is not the same as a finding that CBN is safe or inert.
What do the FDA, NIH and NIDA say about CBN and CBD?
About CBD, a good deal. The FDA has approved one CBD product, a prescription drug for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome or tuberous sclerosis complex. Its consumer page says “CBD can cause liver injury” and “can affect how other drugs you are taking work,” and that “it is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement” (FDA). NIDA lists possible side effects “including drowsiness, decreased appetite, vomiting and diarrhea,” and says some products marketed as CBD have been found to contain THC.
About CBN, almost nothing specific. NIDA’s one mention is the limited-research sentence above. The FDA’s question-and-answer page does not discuss CBN, and says: “With the exception of Epidiolex, Marinol, and Syndros, no product containing cannabis or cannabis-derived compounds (either plant-based or synthetic) has been approved as safe and effective for use in any patient population” (FDA). No CBN product is on that list.
What research exists is indexed by NIH’s National Library of Medicine. A 2022 review calls CBN the “greatest ‘minor’ cannabinoid” and notes that most bioactivity research has gone to THC, CBD, CBG and CBC (Maioli and others, Plants, 2022).
What is not established about CBN?
As of Oct. 14, 2026, the federal sources and studies above establish none of the following:
- Any medical use. No CBN product is FDA-approved, and this page makes no health claim for CBN or CBD.
- The sleep claims in CBN marketing. The 2021 review set out to test them and found “insufficient published evidence to support sleep-related claims” (Corroon, 2021). A 2026 sleep-lab trial gave 20 adults with insomnia a single dose of 30 mg or 300 mg; CBN “did not significantly change” the main measure, minutes awake after first falling asleep. Some secondary measures moved at 300 mg, and the authors say “larger, longer trials are warranted” (Lavender and others, 2026).
- A safety profile in people. The FDA’s CBD warnings come partly from its review of Epidiolex. Nothing comparable exists for CBN.
- Interactions with medicines. Laboratory studies have looked at how CBN affects liver enzymes that process drugs (Yamaori and others, 2012), but no federal agency page we checked gives guidance on CBN and other medicines.
Are CBN and CBD legal under federal law?
As of Oct. 14, 2026, and until Dec. 10, both are inside the hemp definition when they come from hemp. That definition covers the plant “and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers” with “a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis” (7 U.S.C. 1639o). The Controlled Substances Act’s marijuana definition excludes hemp (21 U.S.C. 802).
Schedule I lists “Tetrahydrocannabinols” and says the entry “does not include any material, compound, mixture, or preparation that falls within the definition of hemp.” Neither CBN nor CBD is named on it (21 CFR 1308.11). For CBD, the FDA’s food and supplement bar is a second, separate limit.
What changes for CBN and CBD on Dec. 11, 2026?
Section 781 of P.L. 119-37 rewrites the hemp definition, and sec. 2019 of H.R. 6500 holds most of it until Dec. 11, 2026 (P.L. 119-37; H.R. 6500, enrolled). Three parts of it matter here.
| New rule | What it says | What it means for CBN and CBD |
|---|---|---|
| Total THC | Hemp is measured by “total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid),” at 0.3% dry weight | Their THC content counts; CBN and CBD themselves are not tetrahydrocannabinols |
| Made outside the plant | Excludes products with cannabinoids that “were synthesized or manufactured outside the plant” | A CBN or CBD made by converting another cannabinoid in a lab falls outside hemp |
| 0.4 mg per container | Final products may hold no more than 0.4 mg combined of total THC and “any other cannabinoids that have similar effects (or are marketed to have similar effects)” as THC, “as determined by the Secretary of Health and Human Services” | CBN counts toward the cap only if HHS names it |
The last row is the open question for CBN. The law told the FDA to publish, within 90 days, a list of cannabinoids “with similar effects to, or marketed to have similar effects to,” THC-class cannabinoids. That deadline passed on Feb. 10, 2026. We found no such list in the Federal Register as of Oct. 14, 2026; the Hemp Ban Tracker logs its status, and our 0.4 mg container limit explainer has the arithmetic.
Is CBN or CBD legal in my state?
State law can be stricter than federal law. Our state-by-state legality hub links every State Page, for example Texas, each with its hemp rule and a dated source.
Sources
- What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD, FDA, content current as of March 5, 2020
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD), FDA, content current as of July 16, 2024
- Cannabis (Marijuana), National Institute on Drug Abuse
- Lavender IG and others. “Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial.” J. Sleep Res. 35 (2026): e70284. PubMed 41698831
- Corroon J. “Cannabinol and Sleep: Separating Fact from Fiction.” Cannabis Cannabinoid Res. 6 (2021): 366–371. PubMed 34468204
- Zamengo L and others. “The role of time and storage conditions on the composition of hashish and marijuana samples: A four-year study.” Forensic Sci. Int. 298 (2019): 131–137. PubMed 30901710
- Jaidee W and others. “Kinetics of CBD, Δ9-THC Degradation and Cannabinol Formation in Cannabis Resin at Various Temperature and pH Conditions.” Cannabis Cannabinoid Res. 7 (2022): 537–547. PubMed 34096805
- Karniol IG and others. “Effects of delta9-tetrahydrocannabinol and cannabinol in man.” Pharmacology 13 (1975): 502–512. PubMed 1221432
- Maioli C and others. “Cannabinol: History, Syntheses, and Biological Profile of the Greatest ‘Minor’ Cannabinoid.” Plants 11 (2022): 2896. PubMed 36365350
- Yamaori S and others. Drug Metab. Pharmacokinet. 27 (2012): 294–300. PubMed 22166891
- Taura F, Morimoto S, Shoyama Y. J. Biol. Chem. 271 (1996): 17411–17416. PubMed 8663284
- PubChem: cannabinol, cannabidiol, tetrahydrocannabinol, National Library of Medicine
- P.L. 119-37, sec. 781 and H.R. 6500, enrolled, sec. 2019, GovInfo
- 7 U.S.C. 1639o, 21 U.S.C. 802, 21 CFR 1308.11 and 7 CFR 990.1
Checked against these sources Oct. 14, 2026. This explainer describes chemistry, research and law; it is not medical or legal advice.
Questions readers asked
What is the difference between CBN and CBD?
CBN, cannabinol, forms mostly after harvest, as THC oxidizes with time, heat and light. CBD, cannabidiol, comes from CBDA, an acid the living plant makes from CBGA. NIDA says CBD is not intoxicating like THC and lists CBN among cannabinoids with limited research. Only CBD has an FDA-approved drug, Epidiolex.
How does CBN form?
Mostly from THC breaking down. A 2026 trial report calls CBN an oxidative by-product of delta-9 THC. In a four-year storage study of cannabis samples kept at room temperature, THC fell while CBN rose, and almost all THC was gone after four years. Heat speeds the change; light also changes it.
Does CBN get you high?
The evidence is mixed. NIDA groups CBN with delta-8 THC, HHC and other intoxicating cannabinoids and related compounds on which research is limited. A 2021 review of human studies found the evidence that CBN produces cannabis-like effects mixed, with most of it showing no such effect. NIDA says CBD is not intoxicating like THC.
What do the FDA, NIH and NIDA say about CBN and CBD?
The FDA has approved one CBD drug, Epidiolex, warns that CBD can cause liver injury and interact with other drugs, and says it is illegal to add CBD to food or sell it as a dietary supplement. Apart from Epidiolex, Marinol and Syndros, the FDA has approved no cannabis-derived product, so no CBN product is approved.
What is not established about CBN?
Whether it treats any condition, its safety in people, how it interacts with medicines and how strongly it acts on its own. A 2021 review found insufficient evidence for the sleep claims made in CBN marketing, and a 2026 trial in 20 adults with insomnia found no significant change in its main measure of night waking.
Are CBN and CBD legal under federal law?
As of Oct. 14, 2026, CBN and CBD from hemp fall inside the hemp definition, which covers the plant's cannabinoids when delta-9 THC is at or below 0.3 percent of dry weight. Neither is named in Schedule I. The FDA separately says it is illegal to add CBD to food or sell it as a supplement.
What changes for CBN and CBD on Dec. 11, 2026?
Hemp will be measured by total THC, THCA included. Products holding cannabinoids synthesized or manufactured outside the plant are excluded, and final products may hold at most 0.4 mg per container of total THC plus any cannabinoid HHS finds has, or is marketed to have, THC-like effects. Whether CBN is named is open.
Is CBN or CBD legal in my state?
State law can be stricter than federal law. Each State Page on this site gives the state's rule for the hemp-retail lane with a dated source.
Spotted an error? Write to hello@thcagroup.com and we print the correction here.
Filed under Guides · How we work · Report an error